Pharmaceutical companies face a significant challenge: inadequate awareness among the general public about urological issues, such as kidney stones. This lack of awareness leads to delayed diagnoses, increased healthcare costs, and prolonged patient suffering. Studies reveal that over 1 million cases of kidney stones are diagnosed annually, many of which could be prevented with timely education and intervention.
Moreover, the indirect impact is equally profound. Patients enduring urological issues often experience decreased quality of life, affecting productivity and overall well-being.
At Pixika AI, we specialize in bridging this awareness gap through innovative patient engagement solutions. Our approach integrates best practices in digital and print media to deliver personalized educational materials directly to patients and healthcare providers.
Through web-to-web and web-to-print technologies, we enable pharmaceutical companies to deliver targeted, educational content that resonates with patients, thereby fostering early detection and proactive management of urological conditions.
With a proven track record of partnering with over 70 top global healthcare companies and reaching half a million doctors annually, Pixika AI has facilitated cumulative revenues exceeding 9700 crores. Our partnerships span 8 countries, with a client retention rate of 75% and an average rating of 4.1 stars.
In the realm of healthcare, urology stands out as a critical area where patient engagement and education are often lacking. As we approach Urology Awareness Month 2024, the need to address this issue becomes more pressing than ever.